Literature DB >> 16934605

Orthotopic transplantation of intestinal mucosal organoids in rodents.

Jeffrey R Avansino1, David C Chen, Vicki D Hoagland, Jacob D Woolman, Matthias Stelzner.   

Abstract

BACKGROUND: Orthotopic transplantation of intestinal mucosal organoids that contain putative mucosal stem cells serves as an important step toward implementing intestinal gene therapy and treatment for malabsorption syndromes in animals and humans. We hypothesized that intestinal mucosal organoids can be transplanted along the axis of the small bowel giving rise to a neomucosa expressing proteins of its donor origin.
METHODS: Epithelial organoids were harvested from neonatal mice or rat small intestine with the use of a combination of enzymatic digestion with dispase and collagenase, and gravity sedimentation. In adult syngeneic recipients, a 7-cm segment of midjejunum was isolated, leaving its vascular pedicle intact. The remaining proximal and distal segments were anastomosed to restore intestinal continuity. The isolated segments were randomly subjected to surgical or chemical mucosectomy with a chelator solution for 30, 45, or 60 minutes and then compared. Histologic examination was used to confirm the presence of enterocytes, goblet cells, enteroendocrine cells, and Paneth cells in the neomucosal segments. To confirm the presence of ileal bile acid transporter (IBAT) gene message and function, we measured sodium-dependent bile acid uptake and IBAT-messenger RNA. Immunohistochemical examination using anti-IBAT antibodies was performed to demonstrate the expression of IBAT in the neomucosal segments. Experiments were repeated in a murine model transgenic for the green fluorescent protein to verify donor origin of the engrafted mucosa expressing IBAT.
RESULTS: The area of peak IBAT function was found to be located in the terminal ileum. Organoid units harvested from this region were capable of generating a small-bowel neoileal mucosa after being seeded into the jejunum. This mucosa was histologically confirmed to differentiate into all 4 intestinal lineages and to express IBAT signal, confirming its donor-derived origin. Optimal engraftment of mucosa expressing the IBAT protein was found in isolated jejunal segments debrided for 45 minutes. Sodium-dependent bile acid uptake was 5-fold higher in the neoileum, compared with the jejunum. IBAT-mRNA levels in the neoileum were 18-100-fold higher than those in the jejunum. Areas of green fluorescent protein-positive mucosa stained positively with anti-IBAT antibody in adjacent sections, suggesting that the regenerated mucosa is from transplanted ileal stem cells.
CONCLUSIONS: Orthotopic transplantation of epithelial organoids containing ileal stem cells was used to generate a neoileal mucosa that expressed all 4 intestinal lineages along with a new zone of active bile acid uptake and IBAT expression in a recipient jejunal segment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934605     DOI: 10.1016/j.surg.2006.03.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

Review 1.  A nomenclature for intestinal in vitro cultures.

Authors:  Matthias Stelzner; Michael Helmrath; James C Y Dunn; Susan J Henning; Courtney W Houchen; Calvin Kuo; John Lynch; Linheng Li; Scott T Magness; Martin G Martin; Melissa H Wong; Jian Yu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

2.  Spray Delivery of Intestinal Organoids to Reconstitute Epithelium on Decellularized Native Extracellular Matrix.

Authors:  Dana M Schwartz; Meryem O Pehlivaner Kara; Allan M Goldstein; Harald C Ott; Adam K Ekenseair
Journal:  Tissue Eng Part C Methods       Date:  2017-09       Impact factor: 3.056

Review 3.  Intestinal stem cell transplantation.

Authors:  Tetsuya Nakamura; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2016-11-25       Impact factor: 7.527

Review 4.  Generating intestinal tissue from stem cells: potential for research and therapy.

Authors:  Jonathan C Howell; James M Wells
Journal:  Regen Med       Date:  2011-11       Impact factor: 3.806

Review 5.  Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.

Authors:  Meike Hohwieler; Lukas Perkhofer; Stefan Liebau; Thomas Seufferlein; Martin Müller; Anett Illing; Alexander Kleger
Journal:  United European Gastroenterol J       Date:  2016-09-21       Impact factor: 4.623

Review 6.  An enduring role for quiescent stem cells.

Authors:  Camilla A Richmond; Manasvi S Shah; Diana L Carlone; David T Breault
Journal:  Dev Dyn       Date:  2016-06-01       Impact factor: 3.780

7.  The construction of an oxalate-degrading intestinal stem cell population in mice: a potential new treatment option for patients with calcium oxalate calculus.

Authors:  Zhiqiang Chen; Guanlin Liu; Zhangqun Ye; Debo Kong; Lingfang Yao; Hui Guo; Weimin Yang; Xiao Yu
Journal:  Urol Res       Date:  2011-09-03

Review 8.  Stem cells as a potential future treatment of pediatric intestinal disorders.

Authors:  Troy A Markel; Paul R Crisostomo; Tim Lahm; Nathan M Novotny; Frederick J Rescorla; Joseph Tector; Daniel R Meldrum
Journal:  J Pediatr Surg       Date:  2008-11       Impact factor: 2.545

9.  Intestinal stem cell organoid transplantation generates neomucosa in dogs.

Authors:  Vatche G Agopian; David C Chen; Jeffrey R Avansino; Matthias Stelzner
Journal:  J Gastrointest Surg       Date:  2009-01-23       Impact factor: 3.452

10.  A novel culture system for adult porcine intestinal crypts.

Authors:  Hassan A Khalil; Nan Ye Lei; Garrett Brinkley; Andrew Scott; Jiafang Wang; Upendra K Kar; Ziyad B Jabaji; Michael Lewis; Martín G Martín; James C Y Dunn; Matthias G Stelzner
Journal:  Cell Tissue Res       Date:  2016-03-01       Impact factor: 4.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.